11th November 2020  Product update: rapidmicrobiology staff writer

COVID-19 Rapid Test Centres at German Airports Adopt Fully-Automated Workflow

Centogene N.V and Fujirebio Europe have entered into a partnership to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing with further deployment in German airports.

As part of the agreement, Fujirebio will provide a steady supply of Lumipulse G SARS-CoV-2 Ag assays running on fully automated CLEIA-based LUMIPULSE G1200 instruments. Sample collection is to be performed by Centogene via the usual oropharyngeal swabs, with the analysis of the samples performed at Centogene test laboratories, and the LUMIPULSE G1200 then supporting by delivering high-quality results in up to only 40 minutes from sample receipt in the laboratory.

These instruments will be an integrated part of the existing sophisticated automated Centogene workflow that ensures fast and direct delivery of results to customers on their smartphones or digital devices.

Dr Volkmar Weckesser, Chief Information Officer at Centogene, stated, “Over the past months, we have seen an increasing need for easily accessible, reliable, and rapid coronavirus tests. We have been able to establish a blueprint for this - having set up test centres at four of Germany’s largest airports in the last six months. We are very excited to now expand on these services with the support of Fujirebio’s advanced technology. With this highly validated, customer-friendly solution, we hope to play an integral role in preventing further outbreaks.”

Lumipulse G SARS-CoV-2 Ag was the first high-sensitive antigen assay launched on a fully automated chemiluminescent platform. Japanese authorities have used it since August this year for quarantine screening of arriving travellers in major international Japanese airports.

Centogene has an exclusive cooperation with Lufthansa. The first test runs for these comprehensive, fast and high-quality COVID-19 antigen tests for use on flights from Hamburg will start on November 12th. Lufthansa passengers can have themselves tested free of charge on selected connections before departure.

“With our test strategy, we are pursuing the goal of using the data obtained to collect important knowledge in dealing with antigen tests. We are convinced that it is the only right way further to expand the established test infrastructure at the airports. The cooperation between Lufthansa and Centogene, which are continuously expanding their capacities, serves as a benchmark for a successful test model,” said Christoph Leffers, Head of Task Force Testing Lufthansa Group.

Lumipulse G SARS-CoV-2 Ag assay
The Lumipulse G SARS-CoV-2 Ag assay is used on a LUMIPULSE G system for quantitative measurement of SARS-CoV-2 antigen in human nasopharyngeal swab fluid or saliva. It is used as an aid in the diagnosis of a SARS-CoV-2 infection and utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology.

The assay generates fast results (available in up to 40 minutes from sample receipt in the laboratory) using different sample types, including less invasive saliva samples.



Date Published: 11th November 2020

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.

View full company details